We are Sorry, This Page doesn't Exist
Tonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights
50% of Enrollment Complete for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD Results from RECOVERY Interim Analysis Expected First Quarter 2020 Topline Data Expected Second Quarter 2020 Based on Cu.....»»
AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca reports publication of Fasenra Phase 2 trial results in NEJM
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Syndax reports updated results from Phase 2 ENCORE 601 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Oragenics reports interim safety analysis results from Phase 2 AG013 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca"s Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows
AstraZeneca's updated data from TOPAZ-1 Phase 3 trial of Imfinzi (durvalumab) in advanced biliary tract cancer patients. Unveiling long-term survival benefits and significant overall survival improvement. read more.....»»
Exelixis reports Phase 1b results from Cohort 6 of COSMIC-021 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Spectrum Global Solutions Reports Over $4 Million in Revenue For First Quarter 2021, Narrows Operating Loss for Period
BOCA RATON, Fla., May 17, 2021 (GLOBE NEWSWIRE) -- Spectrum Global Solutions, Inc. (the "Company") (OTCQB:SGSI) reported financial results for the three months ended March 31, and provides a Management Discussion and Analysis. Th.....»»
Ayala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
- First Patient Dosed in Phase 1 AL102 Combination Trial with Novartis' Anti-BCMA Agent for the Treatment of Multiple Myeloma - - On Track to Initiate AL102 Phase 2/3 Pivotal Trial for the Treatment of.....»»
ContraFect Reports First Quarter 2021 Financial Results and Provides Business Update
Interim futility analysis from the Phase 3 DISRUPT study of exebacase evaluating treatment superiority is anticipated in H2 2021 BARDA contract award provides up to $86.8 million for exebacase development Strong fi.....»»
Harte Gold Reports First Quarter 2021 Results, Provides Updated Guidance for 2021 and Initiates Strategic Review
TORONTO, May 13, 2021 /CNW/ - HARTE GOLD CORP. ("Harte Gold" or the "Company") (TSX:HRT) (OTC:HRTFF) (Frankfurt: H4O) announced today its results for the three months ended March 31, 2021. .....»»
Graybug Vision reports full-data analysis from ALTISSIMO phase 2b trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Humanigen reports publication of results from Phase 3 COVID-19 lenzilumab trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioLineRx reports "positive" results from GENESIS Phase 3 trial of motixafortide
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Syndax reports updated data from Phase 1 AUGMENT-101 trial of SNDX-5613
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers reports "positive" results from Phase 3 CheckMate -648 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
CytoDyn reports results from CD12 trial of COVID-19 patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
: AstraZeneca now says its COVID-19 vaccine is 76% effective
AstraZeneca PLC, which has been under fire for the accuracy of its data, on Wednesday night announced updated Phase 3 trial data of its coronavirus vaccine, saying it's 76% effective at preventing symptomatic COVID-19......»»
AstraZeneca reports reduced efficacy of 76% in U.S. Phase III Covid trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Novo Nordisk reports full results of STEP 4 trial were presented at ENDO meeting
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»